DRP1 has been observed to have enhanced expression in GBM and is involved in maintaining GBM stem cell properties, such as initiating and maintaining tumor characteristics, as well as promoting migration and invasiveness, which are core factors in GBM [81]. The gene discussed is DNM1L; the disease is glioblastoma.